Apixaban vs warfarin after heart valve surgery for atrial fibrillation
Part of Heart & circulation clinical trials.
This study compares two blood thinners, apixaban (Eliquis) and warfarin, for people with atrial fibrillation who have just had heart valve surgery (repair or biological replacement). The goal is to see which medicine works better at preventing strokes and blood clots in the first three months after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had open-heart surgery in the last 10 days to repair a heart valve or replace it with a tissue (biological) valve.
- You have atrial fibrillation (irregular heartbeat) and need blood thinners.
- You do not have a mechanical (man-made) heart valve.
- You do not have severe kidney or liver disease, and you are not bleeding or at high risk for bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares aspirin to warfarin in the first six months after receiving a bioprosthetic (tissue) heart valve. It aims to find which treatment better prevents blood clots without causing excessive bleeding.
This study compares two blood-thinning medicines, edoxaban and apixaban, to see which one is better at preventing strokes and bleeding in people who have both atrial fibrillation and coronary artery disease. If you're eligible, you may receive one of these standard treatments, and the trial could help find the safer option.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
This trial tests whether a newer blood thinner, apixaban, works better than the standard warfarin for treating blood clots in the left ventricle after a heart attack. The goal is to see which medication is safer and more effective at preventing complications.
This study compares a blood thinner pill (a factor Xa inhibitor) with warfarin (vitamin K antagonist) in people who have had a mechanical aortic valve replacement. It looks at which option works better and is safer over the long term.
This trial compares two ways to prevent blood clots after open heart surgery: a “direct oral” blood thinner pill versus warfarin (a vitamin K antagonist). It may help find the safest and most effective option for people who develop atrial fibrillation after surgery.
Hear when a new Valve Replacement Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.